APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuroleptics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neuroleptics Industry Growth and Trends Forecast to 2032

20 December 202596 pages

Choose your research edition.

Industry ResearchNeuroleptics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroleptics Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Neuroleptics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroleptics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroleptics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neuroleptics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neuroleptics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neuroleptics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neuroleptics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neuroleptics include Johnson & Johnson, Eli Lilly, Pfizer, GSK, Bristol-Myers Squibb, AstraZeneca and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neuroleptics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neuroleptics market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neuroleptics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neuroleptics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neuroleptics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neuroleptics Market by Company

Johnson & Johnson

Eli Lilly

Pfizer

GSK

Bristol-Myers Squibb

AstraZeneca

Allergan

Neuroleptics Segment by Type

First Generation

Second Generation

Third Generation

Neuroleptics Segment by Application

Bipolar Disorder

Schizophrenia

Unipolar Depression

Dementia

Others

Neuroleptics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroleptics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroleptics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroleptics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neuroleptics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neuroleptics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of First Generation Table 2. Major Company of Second Generation Table 3. Major Company of Third Generation Table 4. Global Neuroleptics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Neuroleptics Sales by Type (2021-2026) & (k tons) Table 6. Global Neuroleptics Sales Market Share in Volume by Type (2021-2026) Table 7. Global Neuroleptics Sales by Type (2021-2026) & (US$ Million) Table 8. Global Neuroleptics Sales Market Share in Value by Type (2021-2026) Table 9. Global Neuroleptics Price by Type (2021-2026) & (US$/ton) Table 10. Global Neuroleptics Sales by Type (2027-2032) & (k tons) Table 11. Global Neuroleptics Sales Market Share in Volume by Type (2027-2032) Table 12. Global Neuroleptics Sales by Type (2027-2032) & (US$ Million) Table 13. Global Neuroleptics Sales Market Share in Value by Type (2027-2032) Table 14. Global Neuroleptics Price by Type (2027-2032) & (US$/ton) Table 15. North America Neuroleptics Sales by Type (2021-2026) & (k tons) Table 16. North America Neuroleptics Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Neuroleptics Sales by Type (2021-2026) & (k tons) Table 18. Europe Neuroleptics Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Neuroleptics Sales by Type (2021-2026) & (k tons) Table 20. Asia-Pacific Neuroleptics Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Neuroleptics Sales by Type (2021-2026) & (k tons) Table 22. Latin America Neuroleptics Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Neuroleptics Sales by Type (2021-2026) & (k tons) Table 24. Middle East and Africa Neuroleptics Sales by Type (2021-2026) & (US$ Million) Table 25. Neuroleptics Industry Trends Table 26. Neuroleptics Industry Drivers Table 27. Neuroleptics Industry Opportunities and Challenges Table 28. Neuroleptics Industry Restraints Table 29. Global Neuroleptics Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Neuroleptics Revenue Market Share by Company (2021-2026) Table 31. Global Neuroleptics Sales by Company (2021-2026) & (k tons) Table 32. Global Neuroleptics Sales Share by Company (2021-2026) Table 33. Global Neuroleptics Market Price by Company (2021-2026) & (US$/ton) Table 34. Global Neuroleptics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Neuroleptics Major Company Production Sites and Headquarters Table 36. Global Neuroleptics Company, Product Type & Application Table 37. Global Neuroleptics Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Neuroleptics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Neuroleptics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Neuroleptics Sales by Region (2021-2026) & (k tons) Table 42. Global Neuroleptics Sales Market Share in Volume by Region (2021-2026) Table 43. Global Neuroleptics Sales by Region (2021-2026) & (US$ Million) Table 44. Global Neuroleptics Sales Market Share in Value by Region (2021-2026) Table 45. Global Neuroleptics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 46. Global Neuroleptics Sales by Region (2027-2032) & (k tons) Table 47. Global Neuroleptics Sales Market Share in Volume by Region (2027-2032) Table 48. Global Neuroleptics Sales by Region (2027-2032) & (US$ Million) Table 49. Global Neuroleptics Sales Market Share in Value by Region (2027-2032) Table 50. Global Neuroleptics Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 51. Global Neuroleptics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Neuroleptics Sales by Application (2021-2026) & (k tons) Table 53. Global Neuroleptics Sales Market Share in Volume by Application (2021-2026) Table 54. Global Neuroleptics Sales by Application (2021-2026) & (US$ Million) Table 55. Global Neuroleptics Sales Market Share in Value by Application (2021-2026) Table 56. Global Neuroleptics Price by Application (2021-2026) & (US$/ton) Table 57. Global Neuroleptics Sales by Application (2027-2032) & (k tons) Table 58. Global Neuroleptics Sales Market Share in Volume by Application (2027-2032) Table 59. Global Neuroleptics Sales by Application (2027-2032) & (US$ Million) Table 60. Global Neuroleptics Sales Market Share in Value by Application (2027-2032) Table 61. Global Neuroleptics Price by Application (2027-2032) & (US$/ton) Table 62. North America Neuroleptics Sales by Application (2021-2026) & (k tons) Table 63. North America Neuroleptics Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Neuroleptics Sales by Application (2021-2026) & (k tons) Table 65. Europe Neuroleptics Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Neuroleptics Sales by Application (2021-2026) & (k tons) Table 67. Asia-Pacific Neuroleptics Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Neuroleptics Sales by Application (2021-2026) & (k tons) Table 69. Latin America Neuroleptics Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Neuroleptics Sales by Application (2021-2026) & (k tons) Table 71. Middle East and Africa Neuroleptics Sales by Application (2021-2026) & (US$ Million) Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Neuroleptics Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Eli Lilly Company Information Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Eli Lilly Neuroleptics Product Portfolio Table 81. Eli Lilly Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Pfizer Neuroleptics Product Portfolio Table 86. Pfizer Recent Development Table 87. GSK Company Information Table 88. GSK Business Overview Table 89. GSK Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. GSK Neuroleptics Product Portfolio Table 91. GSK Recent Development Table 92. Bristol-Myers Squibb Company Information Table 93. Bristol-Myers Squibb Business Overview Table 94. Bristol-Myers Squibb Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Bristol-Myers Squibb Neuroleptics Product Portfolio Table 96. Bristol-Myers Squibb Recent Development Table 97. AstraZeneca Company Information Table 98. AstraZeneca Business Overview Table 99. AstraZeneca Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. AstraZeneca Neuroleptics Product Portfolio Table 101. AstraZeneca Recent Development Table 102. Allergan Company Information Table 103. Allergan Business Overview Table 104. Allergan Neuroleptics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Allergan Neuroleptics Product Portfolio Table 106. Allergan Recent Development Table 107. North America Neuroleptics Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 108. North America Neuroleptics Sales by Country (2021-2026) & (k tons) Table 109. North America Neuroleptics Sales Market Share by Country (2021-2026) Table 110. North America Neuroleptics Sales Forecast by Country (2027-2032) & (k tons) Table 111. North America Neuroleptics Sales Market Share Forecast by Country (2027-2032) Table 112. North America Neuroleptics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Neuroleptics Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Neuroleptics Market Share by Country (2021-2026) Table 115. North America Neuroleptics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Neuroleptics Market Share Forecast by Country (2027-2032) Table 117. Europe Neuroleptics Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 118. Europe Neuroleptics Sales by Country (2021-2026) & (k tons) Table 119. Europe Neuroleptics Sales Market Share by Country (2021-2026) Table 120. Europe Neuroleptics Sales Forecast by Country (2027-2032) & (k tons) Table 121. Europe Neuroleptics Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Neuroleptics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Neuroleptics Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Neuroleptics Market Share by Country (2021-2026) Table 125. Europe Neuroleptics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Neuroleptics Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Neuroleptics Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Neuroleptics Sales by Country (2021-2026) & (k tons) Table 129. Asia-Pacific Neuroleptics Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Neuroleptics Sales Forecast by Country (2027-2032) & (k tons) Table 131. Asia-Pacific Neuroleptics Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Neuroleptics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Neuroleptics Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Neuroleptics Market Share by Country (2021-2026) Table 135. Asia-Pacific Neuroleptics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Neuroleptics Market Share Forecast by Country (2027-2032) Table 137. Latin America Neuroleptics Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 138. Latin America Neuroleptics Sales by Country (2021-2026) & (k tons) Table 139. Latin America Neuroleptics Sales Market Share by Country (2021-2026) Table 140. Latin America Neuroleptics Sales Forecast by Country (2027-2032) & (k tons) Table 141. Latin America Neuroleptics Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Neuroleptics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Neuroleptics Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Neuroleptics Market Share by Country (2021-2026) Table 145. Latin America Neuroleptics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Neuroleptics Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Neuroleptics Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Neuroleptics Sales by Country (2021-2026) & (k tons) Table 149. Middle East and Africa Neuroleptics Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Neuroleptics Sales Forecast by Country (2027-2032) & (k tons) Table 151. Middle East and Africa Neuroleptics Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Neuroleptics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Neuroleptics Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Neuroleptics Market Share by Country (2021-2026) Table 155. Middle East and Africa Neuroleptics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Neuroleptics Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Neuroleptics Distributors List Table 160. Neuroleptics Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Neuroleptics Image Figure 2. Global Neuroleptics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuroleptics Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuroleptics Sales (2021-2032) & (k tons) Figure 5. First Generation Image Figure 6. Global First Generation Sales YoY Growth (2021-2032) & (k tons) Figure 7. Second Generation Image Figure 8. Global Second Generation Sales YoY Growth (2021-2032) & (k tons) Figure 9. Third Generation Image Figure 10. Global Third Generation Sales YoY Growth (2021-2032) & (k tons) Figure 11. Global Neuroleptics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Neuroleptics Market Share by Type 2025 VS 2032 Figure 13. North America Neuroleptics Sales Market Share in Volume by Type in 2025 Figure 14. North America Neuroleptics Sales Market Share in Value by Type in 2025 Figure 15. Europe Neuroleptics Sales Market Share in Volume by Type in 2025 Figure 16. Europe Neuroleptics Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Neuroleptics Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Neuroleptics Sales Market Share in Value by Type in 2025 Figure 19. Latin America Neuroleptics Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Neuroleptics Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Neuroleptics Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Neuroleptics Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Neuroleptics Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Bipolar Disorder Image Figure 26. Global Bipolar Disorder Sales YoY Growth (2021-2032) & (k tons) Figure 27. Schizophrenia Image Figure 28. Global Schizophrenia Sales YoY Growth (2021-2032) & (k tons) Figure 29. Unipolar Depression Image Figure 30. Global Unipolar Depression Sales YoY Growth (2021-2032) & (k tons) Figure 31. Dementia Image Figure 32. Global Dementia Sales YoY Growth (2021-2032) & (k tons) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k tons) Figure 35. Global Neuroleptics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Neuroleptics Market Share by Application 2025 VS 2032 Figure 37. North America Neuroleptics Sales Market Share in Volume by Application in 2025 Figure 38. North America Neuroleptics Sales Market Share in Value by Application in 2025 Figure 39. Europe Neuroleptics Sales Market Share in Volume by Application in 2025 Figure 40. Europe Neuroleptics Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Neuroleptics Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Neuroleptics Sales Market Share in Value by Application in 2025 Figure 43. Latin America Neuroleptics Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Neuroleptics Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Neuroleptics Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Neuroleptics Sales Market Share in Value by Application in 2025 Figure 47. North America Neuroleptics Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. North America Neuroleptics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Neuroleptics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Neuroleptics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Neuroleptics Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Europe Neuroleptics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Neuroleptics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Neuroleptics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Neuroleptics Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Asia-Pacific Neuroleptics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Neuroleptics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Neuroleptics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Neuroleptics Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Latin America Neuroleptics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Neuroleptics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Neuroleptics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Neuroleptics Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 64. Middle East and Africa Neuroleptics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Neuroleptics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Neuroleptics Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Neuroleptics Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Neuroleptics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation
  • Second Generation
  • Third Generation
Applications
  • Bipolar Disorder
  • Schizophrenia
  • Unipolar Depression
  • Dementia
  • Others
Companies covered
  • Johnson & Johnson
  • Eli Lilly
  • Pfizer
  • GSK
  • Bristol-Myers Squibb
  • AstraZeneca
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neuroleptics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neuroleptics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neuroleptics Market by Type
  6. 1.3.1 First Generation
  7. 1.3.2 Second Generation
  8. 1.3.3 Third Generation
  9. 1.4 Global Neuroleptics Market Size by Type
  10. 1.4.1 Global Neuroleptics Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Neuroleptics Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Neuroleptics Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Neuroleptics Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Neuroleptics Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Neuroleptics Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Neuroleptics Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Neuroleptics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neuroleptics Industry Trends
  2. 2.2 Neuroleptics Industry Drivers
  3. 2.3 Neuroleptics Industry Opportunities and Challenges
  4. 2.4 Neuroleptics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neuroleptics Revenue (2021-2026)
  2. 3.2 Global Top Players by Neuroleptics Sales (2021-2026)
  3. 3.3 Global Top Players by Neuroleptics Price (2021-2026)
  4. 3.4 Global Neuroleptics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neuroleptics Major Company Production Sites & Headquarters
  6. 3.6 Global Neuroleptics Company, Product Type & Application
  7. 3.7 Global Neuroleptics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neuroleptics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neuroleptics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neuroleptics Tier 1, Tier 2, and Tier 3
4 Neuroleptics Regional Status and Outlook
  1. 4.1 Global Neuroleptics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neuroleptics Historic Market Size by Region
  3. 4.2.1 Global Neuroleptics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neuroleptics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neuroleptics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neuroleptics Forecasted Market Size by Region
  7. 4.3.1 Global Neuroleptics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neuroleptics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neuroleptics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neuroleptics by Application
  1. 5.1 Neuroleptics Market by Application
  2. 5.1.1 Bipolar Disorder
  3. 5.1.2 Schizophrenia
  4. 5.1.3 Unipolar Depression
  5. 5.1.4 Dementia
  6. 5.1.5 Others
  7. 5.2 Global Neuroleptics Market Size by Application
  8. 5.2.1 Global Neuroleptics Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Neuroleptics Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Neuroleptics Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Neuroleptics Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Neuroleptics Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Neuroleptics Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Neuroleptics Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Neuroleptics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Neuroleptics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Neuroleptics Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Neuroleptics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Neuroleptics Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Neuroleptics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Neuroleptics Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Neuroleptics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GSK Neuroleptics Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 Bristol-Myers Squibb
  26. 6.5.1 Bristol-Myers Squibb Company Information
  27. 6.5.2 Bristol-Myers Squibb Business Overview
  28. 6.5.3 Bristol-Myers Squibb Neuroleptics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb Neuroleptics Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Neuroleptics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Neuroleptics Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Allergan
  38. 6.7.1 Allergan Company Information
  39. 6.7.2 Allergan Business Overview
  40. 6.7.3 Allergan Neuroleptics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Allergan Neuroleptics Product Portfolio
  42. 6.7.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Neuroleptics Sales by Country
  2. 7.1.1 North America Neuroleptics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neuroleptics Sales by Country (2021-2026)
  4. 7.1.3 North America Neuroleptics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neuroleptics Market Size by Country
  6. 7.2.1 North America Neuroleptics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neuroleptics Market Size by Country (2021-2026)
  8. 7.2.3 North America Neuroleptics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neuroleptics Sales by Country
  2. 8.1.1 Europe Neuroleptics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neuroleptics Sales by Country (2021-2026)
  4. 8.1.3 Europe Neuroleptics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neuroleptics Market Size by Country
  6. 8.2.1 Europe Neuroleptics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neuroleptics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neuroleptics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neuroleptics Sales by Country
  2. 9.1.1 Asia-Pacific Neuroleptics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neuroleptics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neuroleptics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neuroleptics Market Size by Country
  6. 9.2.1 Asia-Pacific Neuroleptics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neuroleptics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neuroleptics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neuroleptics Sales by Country
  2. 10.1.1 South America Neuroleptics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neuroleptics Sales by Country (2021-2026)
  4. 10.1.3 South America Neuroleptics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neuroleptics Market Size by Country
  6. 10.2.1 South America Neuroleptics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neuroleptics Market Size by Country (2021-2026)
  8. 10.2.3 South America Neuroleptics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neuroleptics Sales by Country
  2. 11.1.1 Middle East and Africa Neuroleptics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neuroleptics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neuroleptics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neuroleptics Market Size by Country
  6. 11.2.1 Middle East and Africa Neuroleptics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neuroleptics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neuroleptics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neuroleptics Value Chain Analysis
  2. 12.1.1 Neuroleptics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neuroleptics Production Mode & Process
  7. 12.2 Neuroleptics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neuroleptics Distributors
  10. 12.2.3 Neuroleptics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst